11 – 20 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
(
- Contribution to journal › Article
-
Mark
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent : Trajectories of Disease Activity in a Large Multinational Cohort Study
(
- Contribution to journal › Article
-
Mark
Development of the ClinESSDAI : A clinical score without biological domain. A tool for biological studies
(
- Contribution to journal › Article
- 2014
-
Mark
Annual direct medical cost of active systemic lupus erythematosus in five European countries
(
- Contribution to journal › Article
-
Mark
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
(
- Contribution to journal › Article
-
Mark
Health economics and its measures in rheumatoid arthritis
(
- Thesis › Doctoral thesis (compilation)
- 2013
-
Mark
Cancer risk in systemic lupus: An updated international multi-centre cohort study
(
- Contribution to journal › Article
- 2012
-
Mark
Outcome measures for primary Sjogren's syndrome
(
- Contribution to journal › Scientific review
- 2010
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
- 2009
-
Mark
Defining Clinical Criteria for Clinical Remission and Disease Activity in Collagenous Colitis
(
- Contribution to journal › Article